Updated: May 19, 2026

Marc Belsky

KZRKezar Life Sciences, Inc.SEC CIK: 0001382629
Estimated Net Worth
$2.82 Million
Last Updated: May 19, 2026 11:32 PM EST

Transaction Summary

Total Transactions40
Buy-Sell Ratio1.67
Buy Transactions5
Sell Transactions3

Transaction Volume

Total Volume-$2.61M
Net Volume$2.71M
Buy Volume$48.33K
Sell Volume-$2.66M

Trade Analysis

AVG Trade Size-$70.60K
Largest Trade$804.43K
Most Active MonthJan
Most Active Year2019

Trading Sentiment

OverallBullish
Recent TradeNeutral
Last 90 Days0 Trades
ConvictionNone

Net Worth & Trading Activity Over Time

Loading...

Monthly Trading Pattern

Loading...

Past Insider Trading and Trends

Marc Belsky has an estimated net worth of $2.82 Million. This is based on reported shares across multiple companies, which include Kezar Life Sciences, Inc., FIVE PRIME THERAPEUTICS INC, and CELL GENESYS INC.



2016 was Marc Belsky's most active year for acquiring shares with 13 total transactions. Marc Belsky's most active month to acquire stocks was the month of March. 2016 was Marc Belsky's most active year for disposing of shares, totalling 15 transactions. Marc Belsky's most active month to dispose stocks was the month of April. 2016 saw Marc Belsky paying a total of $1,343,785.45 for 121,772 shares, this is the most they've acquired in one year. In 2016 Marc Belsky cashed out on 137,584 shares for a total of $3,197,847.14, their largest year based on trade value.

Holdings & Transactions

KZRkezar life sciences, inc.
Chief Financial Officer
Updated: May 11, 2026VIEW QUOTE
Form TypeSEC Filing
-1.00162.02KMay 11View
0.674.80K12.00KMar 27View
7.20K7.20KMar 04View
24.50K24.50KJan 09View
295.00K295.00KJan 07View
765.00KJul 24View
195.00K195.00KJan 08View
140.00K140.00KJan 05View
220.00K220.00KJan 08View
15.38K$2.60$40.00K17.38KFeb 04View
90.00K90.00KJan 12View
0.67800.00$2.76$2.21K2.00KNov 13View
60.00K60.00KSep 06View
0.20200.00$4.42$884.001.20KAug 20View
1.00500.00$4.82$2.41K1.00KAug 09View
500.00$5.67$2.84K500.00Jul 25 - 26View
60.00K60.00KJan 06View
View
five prime therapeutics inc
Senior Vice President and CFO Officer
Updated: Feb 28, 2018
Form TypeSEC Filing
1.5821.00K78.47KFeb 26View
-0.071.05K$18.42-$19.30K57.47KFeb 05View
-0.05921.00$34.34-$31.63K58.52KSep 01View
-0.2918.88K$44.77-$845.30K59.44KMar 01View
35.16K100.82KFeb 07View
-0.032.28K$48.60-$110.86K65.67KJan 03View
0.3617.98K$44.74$804.43K67.95KSep 01View
0.4335.00K115.93KAug 25View
-0.1934.10K$29.69-$1.39M146.08KScheduledApr 22View
-0.1920.81K$26.29-$780.75K88.92KScheduledApr 06View
-0.1513.88K$22.29-$491.86K81.28KScheduledMar 29 - 30View
13.2075.00K80.68KAug 20View
45.00K45.00KAug 17View
5.68K5.68KApr 30View
30.00K30.00KAug 22View
View
cell genesys inc
VP Finance & CAO Officer
Updated: Oct 15, 2009
Form TypeSEC Filing
-1.00111.46KOct 14View
-0.363.66K$3.11-$11.38K6.46KJul 31View
55.00K55.00KFeb 06View
10.12K10.12KJul 30View
50.00K50.00KDec 01View
View